Literature DB >> 23835527

Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: a retrospective study.

Carolin Hoyer1, Laura Kranaster, Christoph Janke, Alexander Sartorius.   

Abstract

In electroconvulsive therapy (ECT), the use of anesthetics without relevant anticonvulsant properties such as ketamine and etomidate may be favorable for seizure quality. Since there is a relative paucity of studies devoted to this issue, our aim was to compare different anesthetics for ECT regarding their impact on seizure quality and different seizure parameters. We retrospectively compared ketamine (n = 912 anesthesias), etomidate (n = 227 anesthesias), thiopental (n = 2,751 anesthesias), and propofol (n = 42 anesthesias) on their influence on general seizure quality and different seizure parameters by multivariate repeated measurement regression analyses. The use of ketamine and etomidate as anesthetics led to seizures that were overall higher in quality and also longer in motor seizure activity when compared to anesthesia with thiopental and propofol. Ketamine was most favorable concerning central inhibitory potential that was indirectly quantified by concordance and postictal suppression. The worst seizure quality was observed with propofol anesthesia; further, this substance had a negative impact on autonomic activation and seizure duration. Based on the data of this retrospective study, the use of ketamine or etomidate as anesthetic in ECT might be advantageous due to the induction of high-quality seizures.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835527     DOI: 10.1007/s00406-013-0420-5

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  44 in total

1.  BIS during etomidate-induced myoclonus.

Authors:  T A Lim; K Y Lim
Journal:  Anaesthesia       Date:  2006-04       Impact factor: 6.955

Review 2.  The effect of etomidate on adrenal function in critical illness: a systematic review.

Authors:  Stewart G Albert; Srividya Ariyan; Ayesha Rather
Journal:  Intensive Care Med       Date:  2011-03-04       Impact factor: 17.440

3.  Seizure length and clinical outcome in electroconvulsive therapy using methohexital or thiopental.

Authors:  Rachel E Dew; James N Kimball; Peter B Rosenquist; W Vaughn McCall
Journal:  J ECT       Date:  2005-03       Impact factor: 3.635

Review 4.  Augmentation strategies in electroconvulsive therapy.

Authors:  Colleen Loo; Brett Simpson; Ross MacPherson
Journal:  J ECT       Date:  2010-09       Impact factor: 3.635

5.  Factors influencing seizure duration and number of seizures applied in unilateral electroconvulsive therapy. Anaesthetics and benzodiazepines.

Authors:  L S Strömgren; J Dahl; N Fjeldborg; A Thomsen
Journal:  Acta Psychiatr Scand       Date:  1980-08       Impact factor: 6.392

6.  Seizure expression during electroconvulsive therapy: relationships with clinical outcome and cognitive side effects.

Authors:  Tarique D Perera; Bruce Luber; Mitchell S Nobler; Joan Prudic; Christopher Anderson; Harold A Sackeim
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

7.  Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.

Authors:  Andrew D Krystal; Richard D Weiner; Margaret D Dean; Virginia H Lindahl; Louis A Tramontozzi; Grace Falcone; C Edward Coffey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

8.  Comparison of methohexital and etomidate as anesthetic agents for electroconvulsive therapy in affective and psychotic disorders.

Authors:  H Janouschek; T Nickl-Jockschat; M Haeck; B Gillmann; M Grözinger
Journal:  J Psychiatr Res       Date:  2013-02-09       Impact factor: 4.791

9.  Rethinking restimulation: a case report.

Authors:  Laura Kranaster; Christoph Janke; Antje Lewien; Carolin Hoyer; Florian Lederbogen; Alexander Sartorius
Journal:  J ECT       Date:  2012-12       Impact factor: 3.635

10.  Ketamine activation of experimental corticoreticular epilepsy.

Authors:  J A Black; G T Golden; R G Fariello
Journal:  Neurology       Date:  1980-03       Impact factor: 9.910

View more
  30 in total

1.  ECT seizure quality and serum BDNF, revisited.

Authors:  Alexander Sartorius; Jan Malte Bumb; Suna Su Aksay; Peter Gass; Rainer Hellweg; Laura Kranaster
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-02-05       Impact factor: 5.270

2.  S -ketamine compared to etomidate during electroconvulsive therapy in major depression.

Authors:  Maxim Zavorotnyy; Ina Kluge; Kathrin Ahrens; Thomas Wohltmann; Benjamin Köhnlein; Patricia Dietsche; Udo Dannlowski; Tilo Kircher; Carsten Konrad
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-19       Impact factor: 5.270

3.  Reward, memory and prediction of treatment response in affective disorders.

Authors:  Andrea Schmitt; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04       Impact factor: 5.270

4.  Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective study.

Authors:  Laura Kranaster; Carolin Hoyer; Suna Su Aksay; Jan Malte Bumb; F Markus Leweke; Christoph Janke; Manfred Thiel; Beat Lutz; Laura Bindila; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-03-24       Impact factor: 5.270

5.  [Ketamine as anesthetic agent in electroconvulsion therapy].

Authors:  C Janke; J M Bumb; S S Aksay; M Thiel; L Kranaster; A Sartorius
Journal:  Anaesthesist       Date:  2015-05-06       Impact factor: 1.041

6.  Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients.

Authors:  Jan Malte Bumb; Suna Su Aksay; Christoph Janke; Laura Kranaster; Olga Geisel; Peter Gass; Rainer Hellweg; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-09-18       Impact factor: 5.270

7.  Brief vs. ultrabrief pulse ECT: focus on seizure quality.

Authors:  Isabelle Brunner; Michael Grözinger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-07-18       Impact factor: 5.270

8.  A novel Seizure Quality Index based on ictal parameters for optimizing clinical decision making in electroconvulsive therapy. Part 1: development.

Authors:  Laura Kranaster; Suna Su Aksay; Jan Malte Bumb; Carolin Hoyer; Christine Jennen-Steinmetz; Alexander Sartorius
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06-06       Impact factor: 5.270

9.  Overlooking the obvious? Influence of electrolyte concentrations on seizure quality parameters in electroconvulsive therapy.

Authors:  Michael Belz; Isabel Methfessel; Miriam Spang; Matthias Besse; Thorsten Folsche; Caspar Stephani; David Zilles
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-07-17       Impact factor: 5.270

10.  Does remifentanil improve ECT seizure quality?

Authors:  Verònica Gálvez; Phern-Chern Tor; Adriana Bassa; Dusan Hadzi-Pavlovic; Ross MacPherson; Mincho Marroquin-Harris; Colleen K Loo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-04-01       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.